22.04.2016 • News

Valtris Acquires Akcros Chemicals

Valtris Specialty Chemicals, a portfolio company of private equity firm H.I.G. Capital, has acquired specialty chemicals company Akcros Holdings. Financial terms were not disclosed. Akcros is a provider of specialty chemicals used as additives in the production and processing polymers, paints and coatings with operations in Europe and North America. The company has two primary manufacturing sites in Eccles, UK, and New Brunswick, New Jersey, USA, with additional production capacity in Mumbai, India, and Guangzhou, China.

Paul Angus, CEO of Valtris, said Akcros is a highly strategic and complementary acquisition, providing new and multiple avenues for growth. “In addition, Valtris will now be a leading player not only in North America but also in Europe, a major goal of ours,” he said.

Valtris was carved out of Ferro by H.I.G. in December 2014. Akcros is the eleventh acquisition that H.I.G. has completed in the chemicals sector since 2008, and the fourth in the last two years.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read